v3.25.4
Interests in associates - Reconciliation to carrying amounts (Net assets) (Details) - EUR (€)
€ in Thousands
12 Months Ended
May 27, 2025
May 22, 2024
May 22, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Interests in associates            
Profit for the period       € 1,191,267 € 740,870 € 732,458
Other comprehensive income       (1,466,407) 715,902 (630,011)
Dividends paid € (422,515) € (349,162) € (328,623) (422,515) (349,162) (328,623)
Carrying amount       663,652 620,831  
Vifor Fresenius Medical Care Renal Pharma Ltd.            
Interests in associates            
Opening balance net assets (liabilities) January 1,       918,335 893,505  
Profit for the period       456,306 290,766  
Other comprehensive income       (3,428) (116,914)  
Dividends paid       (304,832) (205,301)  
Foreign currency translation       (112,047) 56,279  
Closing balance net assets (liabilities) December 31,       954,334 918,335 € 893,505
Company's share in net assets       429,450 413,251  
Other reconciling items       257,528 219,166  
Eliminations       (54,952) (51,444)  
Carrying amount       € 632,026 € 580,973